NCT06788509 2026-04-13
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Janssen Research & Development, LLC
Phase 1 Enrolling by invitation
Janssen Research & Development, LLC
AvenCell Therapeutics, Inc.
Caribou Biosciences, Inc.
Taiho Oncology, Inc.